J. Weng

L. Shi, Chao Liu, Lulu Chen, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The association between cigarette smoking and serum thyroid stimulating hormone, thyroid peroxidase antibodies and thyroglobulin antibodies levels in Chinese residents: A cross-sectional study in 10 cities

L. Shi, Chao Liu, Lulu Chen, 2019, PloS one.

An Age-Specific Serum Thyrotropin Reference Range for the Diagnosis of Thyroid Diseases in Older Adults: A Cross-Sectional Survey in China.

L. Shi, Chao Liu, Lulu Chen, 2018, Thyroid : official journal of the American Thyroid Association.

Autografting of bone marrow mesenchymal stem cells alleviates streptozotocin-induced diabetes in miniature pigs: Real-time tracing with MRI in vivo

F. Yu, Bao‐ying Li, Xiaoyan Xiao, 2014, International journal of molecular medicine.

Pregnancy outcomes in women with type 1 diabetes in China during 2004 to 2014: A retrospective study (the CARNATION Study)

Jiajun Zhao, Xinhua Xiao, S. Luo, 2021, Journal of Diabetes.

Missense mutation of Pro387Leu in protein tyrosine phosphatase-1B (PTP-1B) is not associated with type 2 diabetes in a Chinese Han population.

J. Weng, Yi Sui, Jinhua Yan, 2003, Diabetes care.

Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations

L. Groop, H. Gu, M. Lehto, 2001, Diabetologia.

Hepatocyte nuclear factor-1β (MODY5) gene mutations in Scandinavian families with early-onset diabetes or kidney disease or both

L. Groop, C. Forsblom, X. Huang, 2000, Diabetologia.

Psychological status of Chinese patients with Type 2 diabetes: data review of Diabcare‐China studies

W. Jia, J. Weng, H. Tian, 2012, Diabetic medicine : a journal of the British Diabetic Association.

A pilot study of preproinsulin peptides reactivity in Chinese patients with type 1 diabetes

Jing Lv, J. Weng, Yingxin Xian, 2019, Diabetes/metabolism research and reviews.

The SRE Motif in the Human PNPLA3 Promoter (−97 to −88 bp) Mediates Transactivational Effects of SREBP‐1c

J. Xu, J. Weng, Hongxia Liu, 2015, Journal of cellular physiology.

Resveratrol in Treating Diabetes and Its Cardiovascular Complications: A Review of Its Mechanisms of Action

J. Weng, Suowen Xu, Meiming Su, 2022, Antioxidants.

Inhibition of obesity-induced hepatic ER stress by early insulin therapy in obese diabetic rats

Jianping Ye, J. Weng, Meng-yin Cai, 2011, Endocrine.

Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.

J. Weng, Wen Xu, Yanbing Li, 2004, Diabetes care.

Efficacy of acarbose in different geographical regions of the world: analysis of a real‐life database

W. Sheu, W. Grzeszczak, H. Watada, 2015, Diabetes/metabolism research and reviews.

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis

Jianping Ye, Jun-yi Yin, J. Weng, 2011, PloS one.

Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus

H. Deng, S. Luo, J. Weng, 2021, Diabetes & metabolism journal.

J. Weng, 2019, Hepatology.

Hepatic functions of GLP-1 and its based drugs: current disputes and perspectives.

T. Jin, J. Weng, 2016, American journal of physiology. Endocrinology and metabolism.

Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription

Wenwen Yin, Yingying Chen, J. Weng, 2014, Diabetologia.

Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice

J. Weng, Fen Xu, B. Lin, 2020, International Journal of Obesity.

Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial

P. Li, Liujun Fu, L. Zeng, 2021, Diabetes, obesity & metabolism.

Insulin therapy improves islet functions by restoring pancreatic vasculature in high‐fat diet‐fed streptozotocin‐diabetic rats (胰岛素治疗通过恢复胰腺血管提高高脂饮食联合链脲佐菌素诱导的糖尿病大鼠的胰岛功能)

J. Weng, Fen Xu, Jinhua Yan, 2014, Journal of diabetes.

Decreased β-Cell Function is Associated with Cardiovascular Autonomic Neuropathy in Chinese Patients Newly Diagnosed with Type 2 Diabetes

H. Deng, Xubin Yang, L. Zeng, 2018, Neuroscience Bulletin.

Serum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake

Chao Liu, J. Weng, W. Teng, 2016, Medicine.

Recognition of maturity‐onset diabetes of the young in China

L. Groop, S. Luo, J. Weng, 2020, Journal of diabetes investigation.

Insight into the biochemical characteristics of a novel glucokinase gene mutation

J. Weng, Hongwei Wang, Meng-yin Cai, 2011, Human Genetics.

Pak1 mediates the stimulatory effect of insulin and curcumin on hepatic ChREBP expression

T. Jin, Ling Liu, J. Chernoff, 2017, Journal of molecular cell biology.

Familial Hypercholesterolemia and Atherosclerosis: Animal Models and Therapeutic Advances

J. Weng, Suowen Xu, 2020, Trends in Endocrinology & Metabolism.

Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway

J. Weng, Yunfeng Shen, Fen Xu, 2019, International journal of endocrinology.

A global assessment of the impact of school closure in reducing COVID-19 spread

G. Leung, S. Mei, K. Leung, 2020, Philosophical Transactions of the Royal Society A.

Status of basal‐supported oral therapy in Chinese type 2 diabetic patients with inadequate glycemic control on oral anti‐diabetic drugs

L. Ji, S. Luo, J. Weng, 2015, Diabetes/metabolism research and reviews.

Liraglutide, Sitagliptin, and Insulin Glargine Added to Metformin: The Effect on Body Weight and Intrahepatic Lipid in Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease

G. Qin, Xinhua Xiao, H. Kuang, 2019, Hepatology.

KLF2 is a therapeutic target for COVID-19 induced endothelial dysfunction

S. Luo, J. Weng, Suowen Xu, 2021, bioRxiv.

Serum IL‐17A concentration and a IL17RA single nucleotide polymorphism contribute to the risk of autoimmune type 1 diabetes

Weijing Zhao, J. Weng, Jiemin Pan, 2022, Diabetes/metabolism research and reviews.

A novel heterozygous deletion in the intron 8–exon 9 boundary of the glucokinase gene in a Chinese pedigree of GCK-MODY

J. Weng, Weibin Zhou, Chengjiang Li, 2017, Acta Diabetologica.

The epidemic study and burden of type 1 diabetes in China

J. Weng, 2018, SCIENTIA SINICA Vitae.

PEDF Expression Is Inhibited by Insulin Treatment in Adipose Tissue via Suppressing 11β-HSD1

H. Deng, J. Weng, Y. Bi, 2013, PloS one.

GLP‐1 Receptor Agonist Exenatide Attenuates the Detrimental Effects of Obesity on Inflammatory Profile in Testis and Sperm Quality in Mice

J. Weng, X. Wen, Fen Xu, 2015, American journal of reproductive immunology.

Rhabdomyolysis in Primary Aldosteronism: A Case Report and Review of the Literature

J. Weng, Wen Xu, Jinhua Yan, 2015 .

Gut microbiome and metabolic activity in type 1 diabetes: An analysis based on the presence of GADA

S. Luo, J. Weng, Wen Xu, 2022, Frontiers in Endocrinology.

The Adenylyl Cyclase Inhibitor MDL-12,330A Potentiates Insulin Secretion via Blockade of Voltage-Dependent K+ Channels in Pancreatic Beta Cells

Qingshan Li, Xiaodong Li, J. Weng, 2013, PloS one.

Diabetes in China: The challenge now

J. Weng, Y. Bi, 2010, Journal of diabetes investigation.

Transient hypoxia reprograms differentiating adipocytes for enhanced insulin sensitivity and triglyceride accumulation

Jianping Ye, Zhanguo Gao, J. Weng, 2015, International Journal of Obesity.

Reply to : “Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus”

J. Weng, 2019 .

High engagement in mobile peer support is associated with better glycemic control in type 1 diabetes: A real‐world study

S. Luo, J. Weng, Wen Xu, 2022, Journal of diabetes investigation.

Current practice, attitude and views of providing pregnancy care for women with type 1 diabetes in China: a qualitative study

S. Luo, J. Weng, Xueying Zheng, 2022, BMJ Open.

Peroxisome proliferator-activated receptor alpha agonist-induced down-regulation of hepatic glucocorticoid receptor expression in SD rats.

X. He, J. Weng, Meng-yin Cai, 2008, Biochemical and Biophysical Research Communications - BBRC.

High-risk genotypes for type 1 diabetes are associated with the imbalance of gut microbiome and serum metabolites

S. Luo, J. Weng, Wen Xu, 2022, Frontiers in Immunology.

Iodine Status and Prevalence of Thyroid Disorders After Introduction of Mandatory Universal Salt Iodization for 16 Years in China: A Cross-Sectional Study in 10 Cities.

Lixin Shi, Bingyin Shi, Jianping Weng, 2016, Thyroid : official journal of the American Thyroid Association.

Two Novel MicroRNA Biomarkers Related to &bgr;-Cell Damage and Their Potential Values for Early Diagnosis of Type 1 Diabetes

Yunxia Zhu, Xiao Han, Jianping Ye, 2018, The Journal of clinical endocrinology and metabolism.

Sequential Versus Continual Purified Urinary FSH/hCG in Men With Idiopathic Hypogonadotropic Hypogonadism.

G. Ning, L. Shi, Zuojie Luo, 2015, The Journal of clinical endocrinology and metabolism.

Adult‐onset type 1 diabetic patients with less severe clinical manifestation have less risk DR‐DQ genotypes than childhood‐onset patients

L. Groop, J. Bei, S. Luo, 2020, Diabetes/metabolism research and reviews.

Jiang He, H. Tian, W. Jia, 2014, PloS one.

Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial

H. Tian, Xiang Yan, L. Shi, 2008, The Lancet.

Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.

M. Roden, U. Broedl, H. Woerle, 2013, The lancet. Diabetes & endocrinology.

Short-Term Intensive Therapy in Newly Diagnosed Type 2 Diabetes Partially Restores Both Insulin Sensitivity and β-Cell Function in Subjects With Long-Term Remission

J. Weng, Yun Hu, Lirong Li, 2011, Diabetes Care.

Incidence of Type 1 Diabetes May Be Underestimated in the Chinese Population: Evidence From 21.7 Million People Between 2007 and 2017. Diabetes

Lixin Guo, J. Weng, Zhiguang Zhou, 2021 .

Prevalence of cardiovascular disease and risk factors in the Chinese population with impaired glucose regulation: the 2007-2008 China national diabetes and metabolic disorders study.

H. Tian, W. Jia, G. Shan, 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Prevalence of Hypertension in China: A Cross-Sectional Study

Tao Chen, Li-xiang Lin, H. Tian, 2013, PloS one.

Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial

W. Jia, Y. Mu, L. Ji, 2017, Science China Life Sciences.

Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes

H. Deng, Xubin Yang, J. Weng, 2019, Science China Life Sciences.

Worse pancreatic β-cell function and better insulin sensitivity in older Chinese without diabetes.

H. Tian, W. Jia, L. Ji, 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

Association of Genetic Variants with Isolated Fasting Hyperglycaemia and Isolated Postprandial Hyperglycaemia in a Han Chinese Population

H. Tian, W. Jia, Gang Chen, 2013, PloS one.

Identification of Novel T1D Risk Loci and Their Association With Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide Association Study

Hongbing Shen, J. She, C. Polychronakos, 2019, Diabetes Care.

Asymptomatic patients and asymptomatic phases of Coronavirus Disease 2019 (COVID-19): a population-based surveillance study

S. Luo, J. Weng, T. Jin, 2020, National science review.

Incidence of type 1 diabetes in China, 2010-13: population based study

W. Jia, Y. Mu, L. Ji, 2018, British Medical Journal.

Caveolin-1 deficiency protects pancreatic β cells against palmitate-induced dysfunction and apoptosis.

Shuo Lin, L. Zeng, J. Weng, 2018, Cellular signalling.

Metformin, Macrophage Dysfunction and Atherosclerosis

P. Little, J. Weng, Suowen Xu, 2021, Frontiers in Immunology.

Acute Wnt pathway activation positively regulates leptin gene expression in mature adipocytes.

I. G. Fantus, Ling Liu, Xiao-Hong Wei, 2015, Cellular signalling.

The expression of dominant negative TCF7L2 in pancreatic beta cells during the embryonic stage causes impaired glucose homeostasis

T. Jin, T. Liang, J. Weng, 2015, Molecular metabolism.

Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study.

Xiaohui Guo, Jianping Weng, Wen Xu, 2016, The lancet. Diabetes & endocrinology.

Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function

D. Eizirik, Boxu Ren, Q. Gong, 2018, Diabetologia.

Targeting angiopoietin‐like 3 in atherosclerosis: From bench to bedside

J. Ge, S. Luo, J. Weng, 2021, Diabetes, obesity & metabolism.

Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammation.

Jianping Ye, Zhanguo Gao, Jun-yi Yin, 2010, Endocrinology.

High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes

C. Lindgren, L. Groop, T. Tuomi, 1999, Diabetologia.

Prevalence of diabetes among men and women in China.

Wenying Yang, Zhigang Zhao, Haoming Tian, 2010, The New England journal of medicine.

Targeting inflammation and cytokine storm in COVID-19

S. Luo, J. Weng, Suowen Xu, 2020, Pharmacological Research.

Statins: Multiple neuroprotective mechanisms in neurodegenerative diseases

Xiaohong Chen, J. Weng, M. Yenari, 2011, Experimental Neurology.

Short-Term Curcumin Gavage Sensitizes Insulin Signaling in Dexamethasone-Treated C57BL/6 Mice.

I. G. Fantus, T. Jin, Burton B. Yang, 2015, The Journal of nutrition.

Standards of medical care for type 2 diabetes in China 2019

Qifu Li, W. Jia, L. Shi, 2019, Diabetes/metabolism research and reviews.

Diet‐induced obesity and insulin resistance are associated with brown fat degeneration in SIRT1‐deficient mice

Jianping Ye, J. Weng, Meng-yin Cai, 2016, Obesity.

Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID‐19: A continuous glucose monitoring‐based observational study

S. Luo, J. Weng, Wen Xu, 2021, Journal of diabetes investigation.

A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope

T. Jin, J. Weng, Zekai Wu, 2018, Science China Life Sciences.

Short‐term intensive insulin therapy at diagnosis in type 2 diabetes: plan for filling the gaps

J. Woo, L. Ji, J. Weng, 2015, Diabetes/Metabolism Research Reviews.

Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the CONFIDENCE study)

T. Yang, L. Ji, J. Lu, 2015, Journal of internal medicine.

SIRT1 Mediates the Effect of GLP-1 Receptor Agonist Exenatide on Ameliorating Hepatic Steatosis

J. Weng, Fen Xu, Haixia Xu, 2014, Diabetes.

Secondary diabetic ketoacidosis and severe hypoglycaemia in patients with established type 1 diabetes mellitus in China: a multicentre registration study

J. Weng, Jinhua Yan, Daizhi Yang, 2014, Diabetes/metabolism research and reviews.

Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.

K. Fox, Y. Mu, D. Hu, 2013, The American journal of medicine.

Nanotechnology's application in Type 1 diabetes.

S. Luo, J. Weng, Wen Pan, 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

Serum Lipids and Lipoproteins in Chinese Men and Women

Jiang He, Li-xiang Lin, H. Tian, 2012, Circulation.

Effects of Metformin Added to Insulin in Adolescents with Type 1 Diabetes: An Exploratory Crossover Randomized Trial

H. Deng, Xubin Yang, Jing Lv, 2020, Journal of diabetes research.

A look into the future: improving diabetes care by 2015

S. Gough, M. Peyrot, D. Schneider, 2011, Current medical research and opinion.

Use of a do-it-yourself artificial pancreas system is associated with better glucose management and higher quality of life among adults with type 1 diabetes

S. Luo, J. Weng, Wen Xu, 2020, Therapeutic advances in endocrinology and metabolism.

Association between Urinary Iodine Concentration and Thyroid Nodules in Adults: A Cross-Sectional Study in China

L. Shi, Chao Liu, Lulu Chen, 2020, BioMed research international.

Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study

W. Jia, Liming Chen, B. Shi, 2018, Journal of Diabetes Investigation.

The validity and reliability of the revised Chinese version of diabetes self-management scales for adult type 1 diabetes patients

S. Luo, J. Weng, Wen Xu, 2019 .

A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope

T. Jin, J. Weng, Zekai Wu, 2018, Science China Life Sciences.

The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.

N. Xu, J. Weng, Yun Hu, 2010, Clinical therapeutics.

Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort.

R. Ozaki, J. Chan, W. So, 2014, The lancet. Diabetes & endocrinology.

Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)

L. Ji, Lixin Guo, J. Weng, 2022, Cardiology Plus.

Management of Chinese patients with type 2 diabetes, 1998-2006: the Diabcare-China surveys.

W. Jia, H. Tian, J. Weng, 2009, Current medical research and opinion.

Impact of HbA1c Testing at Point of Care on Diabetes Management

J. Weng, O. Schnell, J. Crocker, 2017, Journal of diabetes science and technology.

Comparative effectiveness and safety of different basal insulins in a real‐world setting

S. Garg, S. Paul, W. Jia, 2017, Diabetes, obesity & metabolism.

Cross-Sectional and Longitudinal Replication Analyses of Genome-Wide Association Loci of Type 2 Diabetes in Han Chinese

Jiang He, Qi Zhao, K. Mills, 2014, PloS one.

Impact of Waist Circumference and Body Mass Index on Risk of Cardiometabolic Disorder and Cardiovascular Disease in Chinese Adults: A National Diabetes and Metabolic Disorders Survey

Li-xiang Lin, H. Tian, W. Jia, 2013, PloS one.

Consensus of Chinese experts on strengthening personalized prevention and treatment of type 2 diabetes.

Chao Liu, L. Ji, J. Weng, 2023, Primary care diabetes.

Short-Term Intensive Insulin Therapy in Patients with Newly Presenting Type 2 Diabetes

D. Owens, J. Weng, Wen Xu, 2018 .

The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study

Li-xiang Lin, H. Tian, W. Jia, 2017, Scientific Reports.

Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation (JADE) Registry

R. Ozaki, J. Chan, W. So, 2016, Diabetic medicine : a journal of the British Diabetic Association.

Current role of short‐term intensive insulin strategies in newly diagnosed type 2 diabetes (短期胰岛素强化治疗策略对初诊2型糖尿病患者的作用)

J. Weng, Wen Xu, 2013, Journal of diabetes.

Current status of metformin in addition to insulin therapy in adult patients with type 1 diabetes mellitus: An analysis from the Guangdong Type 1 Diabetes Mellitus Translational Medicine Study

S. Luo, J. Weng, Wen Xu, 2020, Journal of diabetes.

Association between Family History Risk Categories and Prevalence of Diabetes in Chinese Population

Li-xiang Lin, H. Tian, W. Jia, 2015, PloS one.

Association between Family History Risk Categories and Prevalence of Diabetes in

H. Tian, W. Jia, Qiang Li, 2015 .

Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice.

Jianping Ye, Zhanguo Gao, Jun-yi Yin, 2012, Endocrinology.

Targeting metabolic syndrome: Candidate natural agents

J. Weng, X. Xia, 2010, Journal of diabetes.

Evolution in the Chinese Diabetes Society Standards of Care for Type 2 Diabetes

Jianping Weng, J. Weng, 2016, Diabetes/metabolism research and reviews.

Effectiveness of a WeChat Combined Continuous Flash Glucose Monitoring System on Glycemic Control in Juvenile Type 1 Diabetes Mellitus Management: Randomized Controlled Trial

W. Lu, Weijing Zhao, J. Weng, 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

The Awareness of Preconception Counseling in Childbearing Age Women with Type 1 Diabetes Mellitus in China

Jing Lv, S. Luo, J. Weng, 2018, Diabetes.

Current practice and perspectives of healthcare providers regarding preconception care for women with type 1 diabetes in China

S. Luo, J. Weng, Xueying Zheng, 2021, Diabetes/metabolism research and reviews.

Curcumin and other dietary polyphenols: potential mechanisms of metabolic actions and therapy for diabetes and obesity.

I. G. Fantus, T. Jin, J. Weng, 2018, American journal of physiology. Endocrinology and metabolism.

"Chinese guideline for type 2 diabetes mellitus" comprises Chinese characters

J. Weng, 2009 .

Hyperglycemia and duration of diabetes as risk factors for abnormal lipids: a cross sectional survey of 19,757 patients with type 2 diabetes in China

Xilin Yang, W. Jia, L. Ji, 2014, Journal of Endocrinological Investigation.

A multicentre demonstration project to evaluate the effectiveness and acceptability of the web‐based Joint Asia Diabetes Evaluation (JADE) programme with or without nurse support in Chinese patients with Type 2 diabetes

R. Ozaki, A. Kong, J. Chan, 2016, Diabetic medicine : a journal of the British Diabetic Association.

Association of Population Migration and Coronavirus Disease 2019 Epidemic Control

S. Luo, J. Weng, Xueying Zheng, 2020, medRxiv.

Nonlaboratory-Based Risk Assessment Algorithm for Undiagnosed Type 2 Diabetes Developed on a Nation-Wide Diabetes Survey

Wenying Yang, Haoming Tian, Jianping Sun, 2013, Diabetes Care.

The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study

H. Tian, D. Hu, L. Ji, 2019, Scientific reports.

Glycaemic control and its associated factors in Chinese adults with type 1 diabetes mellitus

Shuo Lin, J. Weng, Xueying Zheng, 2015, Diabetes/metabolism research and reviews.

Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate

Xin Gao, J. Weng, Yuying Zhang, 2011, Laboratory Investigation.

Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline Characteristics.

Y. Li, S. Garg, W. Jia, 2015, Diabetes Technology & Therapeutics.

Safety of reopening universities and colleges using a combined strategy during coronavirus disease 2019 in China: a cross-sectional study

Xiao-Shuang Zheng, S. Luo, J. Weng, 2020, SSRN Electronic Journal.

Three-month outcomes of recovered COVID-19 patients: prospective observational study

S. Luo, J. Weng, Xueying Zheng, 2021, Therapeutic advances in respiratory disease.

Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetes.

J. Chan, N. Sartorius, J. Lam, 2013, Journal of affective disorders.

Determinants of poor glycemic control in Chinese men with type 2 diabetes: a cross-sectional survey of 15,427 men in 77 tertiary hospitals in China

Xilin Yang, W. Jia, L. Ji, 2015, International Journal of Diabetes in Developing Countries.

Non-pharmaceutical factors for poor glycemic control in 13,970 Chinese women with drug-treated type 2 diabetes: a cross-sectional survey in 77 tertiary hospitals in four Chinese cities

Xilin Yang, L. Ji, J. Weng, 2014, Patient preference and adherence.

HLA class I genes modulate disease risk and age at onset together with DR-DQ in Chinese patients with insulin-requiring type 1 diabetes

L. Groop, G. Lin, J. Bei, 2021, Diabetologia.

Status of blood glucose control and treatment of type 2 diabetes in China

H. Tian, W. Jia, Li Chen, 2012 .

Albuminuria: Prevalence, associated risk factors and relationship with cardiovascular disease

Li-xiang Lin, H. Tian, W. Jia, 2013, Journal of diabetes investigation.

Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory element-binding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in high-fat-diet and streptozotocin-induced diabetic rats.

J. Weng, Meng-yin Cai, Chunxiao Wang, 2009, Metabolism: clinical and experimental.

Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial

H. Deng, J. Weng, Wen Xu, 2020, BMJ Open.

Short‐term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9%

J. Weng, 2017, Journal of diabetes.

Hot topics on diabetes in China

P. Pozzilli, J. Weng, 2015, Diabetes/metabolism research and reviews.

6q24 transient neonatal diabetes mellitus: the first case report from China.

J. Weng, Wen Xu, Meng-yin Cai, 2014, Chinese medical journal.

Clinical Characteristics of Fulminant Type 1 Diabetes Compared with Typical Type 1 Diabetes: One-Year Follow-Up Study from the Guangdong T1DM Translational Medicine Study

S. Luo, J. Weng, Wen Xu, 2020, Journal of diabetes research.

Predicting in-hospital outcomes of patients with acute kidney injury

D. Hong, Ying Tang, Chunbo Chen, 2023, Nature communications.

Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence

J. Chan, D. Morisky, N. Sartorius, 2015, Journal of diabetes.

Hyperglycemia and Blood Pressure Treatment Goal: A Cross Sectional Survey of 18350 Patients with Type 2 Diabetes in 77 Tertiary Hospitals in China

W. Jia, L. Ji, J. Weng, 2014, PloS one.

Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complications (使用磺脲类药物和胰岛素增加糖尿病并发症的担心并无事实根据)

Xilin Yang, J. Weng, 2014, Journal of diabetes.

Comparative efficacy and safety of long‐acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta‐analyses

Y. Hao, J. Weng, Dalong Zhu, 2011, Journal of diabetes investigation.

The risk factors of glycemic control, blood pressure control, lipid control in Chinese patients with newly diagnosed type 2 diabetes _ A nationwide prospective cohort study

H. Tian, D. Hu, L. Ji, 2019, Scientific Reports.

Management of Chinese patients with type 2 diabetes, 1998–2006: the Diabcare-China surveys

W. Jia, H. Tian, J. Weng, 2009, Current medical research and opinion.

Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study

D. Hu, L. Ji, J. Weng, 2016, PloS one.

Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies.

W. Xu, J. Weng, Xinchun Li, 2015, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Data-driven subgroups of newly diagnosed type 2 diabetes and the relationship with cardiovascular diseases at genetic and clinical levels in Chinese adults.

Tong Jia, Ran Wei, H. Deng, 2023, Diabetes & metabolic syndrome.

Statin initiation and risk of incident kidney disease in patients with diabetes

Mengchun Gong, Fan Luo, J. Weng, 2023, Canadian Medical Association Journal.

China type 2 diabetes treatment status survey of treatment pattern of oral drugs users

H. Tian, W. Jia, L. Ji, 2015, Journal of diabetes.

Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide, non-interventional, observational study data pool.

W. Sheu, W. Grzeszczak, H. Watada, 2016, Journal of diabetes and its complications.

T. Yang, L. Ji, J. Lu, 2015, Journal of internal medicine.

Serum Lipids and Lipoproteins in Chinese Men and Women

Jiang He, Li-xiang Lin, H. Tian, 2012, Circulation.

Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function